Restricted access


FIELDS AND METHODS


BIOalternatives thoroughly uses up-to-date in vitro technologies. Our platform is based on the cellular and molecular pharmacology expertise.


The company proposes access to:
Imaging technologies,
High Content Cellular Screening,
Transcriptomics.

fields and methods
 

PATHWAYS & TARGETS

Cellular and Molecular Toxicology
  • viability
  • cytotoxicity profiling
  • apoptosis
  • phototoxicity...


Differentiation
  • migration
  • adhesion
  • proliferation
  • morphology...


Metabolism
  • energy
  • protein
  • lipid...


Extracellular Matrix
  • synthesis
  • organization
  • degradation


Communication
  • growth factors
  • chemokines
  • cytokines,
  • neurotransmitters...


Signal Transduction
  • Ca2+ mobilization
  • cAMP...


Stress
  • reactive oxygen species
  • intoxication...

TOOLS & METHODS

Cell and tissue culture
  • isolation
  • typing
  • histology...


Bioimaging
  • miscroscopy (light, confocal, electron)
  • high resolution fixed and living cell analysis


Immunoassays
  • ELISA
  • flow cytometry
  • western blot
  • immunochemistry
  • immunofluorescence


Molecular Biology
  • microarrays
  • quantitative RT-PCR
  • cell transfection
  • siRNA


Biochemistry
  • absorbance
  • fluorescence,
  • chemiluminescence
  • radioactivity




Pop2
 
Top

News

Health and Foods...

aliment sante

BIOalternatives will be present at the exposition center of " Health and Foods Days - La Rochelle" 11 - 12 of June 2008.

More...

qPCRarrays ...

photo LC480

Discover the expression profile of your favorite genes in a panel of 62 skin-related models...

More...

FCE Cosmetique...

FCE cosmetique

BIOalternatives will be present at " FCE Cosmetique 2008" São-Paulo City, May 27 - 29, 2008.

More...

Health and Foods...

aliment sante

BIOalternatives will be present at the exposition center of " Health and Foods Days - La Rochelle" 11 - 12 of June 2008.

More...

Pharmaceutical news

qPCRarrays ...

photo LC480

Discover the expression profile of your favorite genes in a panel of 62 skin-related models...

More...